Cargando…

Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma

PURPOSE: To investigate the use of pretreatment carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen (CEA) as prognostic factors to determine survival in pancreatic adenocarcinoma. MATERIALS AND METHODS: A retrospective review of the medical records of patients who were diagnosed with pancrea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kyong Joo, Yi, Seung Woo, Chung, Moon Jae, Park, Seung Woo, Song, Si Young, Chung, Jae Bock, Park, Jeong Youp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635646/ https://www.ncbi.nlm.nih.gov/pubmed/23549809 http://dx.doi.org/10.3349/ymj.2013.54.3.643

Ejemplares similares

Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response
por: Park, Semi, et al.
Publicado: (2013)

Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma
por: Ermiah, Eramah, et al.
Publicado: (2022)

Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer
por: Chung, Joo Won, et al.
Publicado: (2017)

Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis
por: Lee, Hee Seung, et al.
Publicado: (2018)

Clinical Value of Contrast-Enhanced Harmonic Endoscopic Ultrasonography in the Differential Diagnosis of Pancreatic and Gallbladder Masses
por: Leem, Galam, et al.
Publicado: (2018)

Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer
por: Lee, Hee Seung, et al.
Publicado: (2018)

Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
por: Moon, Do Chang, et al.
Publicado: (2016)

Clinical characteristics of second primary pancreatic cancer
por: Jo, Jung Hyun, et al.
Publicado: (2017)

A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer
por: Lee, Kyong Joo, et al.
Publicado: (2016)

BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients
por: Park, Ji Hoon, et al.
Publicado: (2022)

The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.
por: Lundin, J., et al.
Publicado: (1994)

Clinical Implications and Risk Factors of Acute Pancreatitis after Cardiac Valve Surgery
por: Chung, Joo Won, et al.
Publicado: (2013)

Gastrointestinal Hemorrhage after Concurrent Chemoradiotherapy in Locally Advanced Pancreatic Cancer
por: Lee, Kyong Joo, et al.
Publicado: (2013)

Prognostic Factors and Characteristics of Pancreatic Neuroendocrine Tumors: Single Center Experience
por: Oh, Tak Geun, et al.
Publicado: (2012)

Duodenal adenocarcinoma following a neuroendocrine tumor in the duodenum
por: Kim, Bun, et al.
Publicado: (2014)

A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
por: Jo, Jung Hyun, et al.
Publicado: (2022)

Clinicopathologic Characteristics Associated with Complications and Long-Term Outcomes of Endoscopic Papillectomy for Adenoma
por: Shim, Choong Nam, et al.
Publicado: (2014)

Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer
por: Lee, Jeung Eun, et al.
Publicado: (2020)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

Clinical importance of serum CEA and CA-19-9 levels in oesophagogastric junction adenocarcinomas
por: Sert, Ozlem Zeliha, et al.
Publicado: (2020)

The Efficacy of Endoscopic Palliation of Obstructive Jaundice in Hepatocellular Carcinoma
por: Park, Semi, et al.
Publicado: (2014)

Statin Use and Its Impact on Survival in Pancreatic Cancer Patients
por: Lee, Hee Seung, et al.
Publicado: (2016)

Validation of Group B Borderline Resectable Pancreatic Cancer: Retrospective Analysis
por: Oh, Tak Geun, et al.
Publicado: (2014)

Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
por: Kang, Huapyong, et al.
Publicado: (2018)

Radiotherapy Prolongs Biliary Metal Stent Patency in Malignant Pancreatobiliary Obstructions
por: Park, Semi, et al.
Publicado: (2013)

Establishment of pancreatic cancer cell lines with endoscopic ultrasound‐guided biopsy via conditionally reprogrammed cell culture
por: Lee, Hee Seung, et al.
Publicado: (2019)

Impact of UGT1A1 Polymorphisms on Febrile Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX: A Single-Center Cohort Study
por: Keum, Jiyoung, et al.
Publicado: (2022)

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
por: Liang, Lei, et al.
Publicado: (2021)

Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia
por: Kim, Nam Hee, et al.
Publicado: (2017)

The Clinical Significance of CEA, CA19–9, and CA125 in Management of Appendiceal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

Endoscopic Papillary Balloon Dilation with Large Balloon after Limited Sphincterotomy for Retrieval of Choledocholithiasis
por: Bang, Seungmin, et al.
Publicado: (2006)

Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma
por: Kim, Si-Young, et al.
Publicado: (2021)

Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis
por: Kim, Myongjin, et al.
Publicado: (2021)

FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
por: Cho, In Rae, et al.
Publicado: (2020)

Cholecystectomy for Prevention of Recurrence after Endoscopic Clearance of Bile Duct Stones in Korea
por: Song, Myung Eun, et al.
Publicado: (2016)

Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer
por: Kang, Huapyong, et al.
Publicado: (2022)

Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses
por: Park, Se Woo, et al.
Publicado: (2016)

Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
por: Lakemeyer, Leilani, et al.
Publicado: (2021)

The Relationship of Anatomic Variation of Pancreatic Ductal System and Pancreaticobiliary Diseases
por: Bang, Seungmin, et al.
Publicado: (2006)

Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer
por: Park, Chan Su, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_53k12987e59d2ukqucd4147mo6